BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
11/24/20 Reata Pharmaceuticals (RETA) Omaveloxolone for Friedreich's Ataxia Subscribers Only Subscribers Only Subscribers Only
11/24/20 Urovant Sciences (UROV) Vibegron for Irritable Bowel Syndrome (IBS) Subscribers Only Subscribers Only Subscribers Only
11/23/20 Idorsia (SIX: IDIA) clazosentan for Hemorrhagic Stroke / Intracerebral Hemorrhage (ICH) Subscribers Only Subscribers Only Subscribers Only
11/23/20 AstraZeneca (AZN) AZD1222 for COVID-19 Prevention Subscribers Only Subscribers Only Subscribers Only
11/20/20 DNAtrix DNX-2401 for Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
11/26/20 Subscribers Only Subscribers Only Progress Update - Product Launch (Japan)
11/27/20 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 11/28/20 Subscribers Only Subscribers Only Patent - Expiration
Now - 11/28/20 Subscribers Only Subscribers Only Patent - Expiration
Back to the top Back to the top